New drugs, techniques promising, but more data needed
New York-Some antifibrosis drugs and techniques on the horizon appear promising, but more data, especially from controlled human trials, are needed, Paul J. Lama, MD, told those attending the Glaucoma 2006 meeting here.
SLT appears effective for steroid-induced glaucoma
New York-The idea of using selective laser trabeculoplasty (SLT) for steroid-induced glaucoma originated with a patient's stubborn resistance to surgery, according to Janet P. Serle, MD.
Imaging devices may help with glaucoma detection
New York-Some imaging devices may help predict which patients will develop glaucoma, but "they will not supplant clinical assessment of the optic disc by a trained observer," said Christopher A. Girkin, MD, MSPH, to attendees of the Glaucoma 2006 meeting here.
XFS puts individuals at great risk for blindness
New York-A patient with exfoliation syndrome (XFS) may have the worst type of open-angle glaucoma, according to Robert Ritch, MD, who opened a session on XFS at the Glaucoma 2006 meeting.
Device provides option for selected glaucoma patients
New York-The Ex-PRESS glaucoma implant (Optonol) is a device that may be coming into its own, at least for some selected patients undergoing glaucoma surgery, Robert D. Fechtner, MD, reported at the Glaucoma 2006 meeting here.
Gold micro-shunt shows promise for lowering IOP
New York-A gold micro-shunt (GMS, SOLX) implant holds promise for reducing complications of trabeculectomy by lowering IOP, said Celso Tello, MD.
Learn how to recognize, manage bleb leaks
Surgeon outlines potential remedies such as medical therapy, tamponade, adhesives
Time of day, patient assessments help in dry eye diagnosis
Fort Lauderdale, FL-When assessing a patient with dry eye, clinicians should keep the time of day in mind, said Carolyn G. Begley, OD, MS.
CA-The FDA approval of gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) marks a milestone as the first fourth-generation fluoroquinolone to enter the ophthalmic market. The therapy for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria also has a unique mechanism to prevent development of antibiotic resistance, according to Allergan.
Race, ethnicity revisited in glaucoma symposium
Baltimore-Race, that ever-sensitive subject in American culture, was the focus of a day-long meeting, "Ethnicity & Glaucoma: The Past, Present, and Future," at Johns Hopkins' Bloomberg School of Public Health.
NSAIDs may interfere with glaucoma medication
San Antonio, TX-Before prescribing one of the newer medications for glaucoma, clinicians should ask what drugs the patient may be taking for aches and pains-especially non-steroidal anti-inflammatory agents (NSAIDs), including something as innocuous as aspirin, said William E. Sponsel, MD.
2 Clarke Drive Cranbury, NJ 08512